Unity Biotechnology Correlations

UBX Stock  USD 1.21  0.02  1.68%   
The current 90-days correlation between Unity Biotechnology and Cue Biopharma is 0.29 (i.e., Modest diversification). The correlation of Unity Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Unity Biotechnology Correlation With Market

Average diversification

The correlation between Unity Biotechnology and DJI is 0.12 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Unity Biotechnology and DJI in the same portfolio, assuming nothing else is changed.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Unity Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy Unity Stock please use our How to Invest in Unity Biotechnology guide.

Moving together with Unity Stock

  0.65HLN Haleon plcPairCorr
  0.72JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.9LLY Eli Lilly Sell-off TrendPairCorr
  0.82MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.74PFE Pfizer Inc Aggressive PushPairCorr
  0.88RDY Dr Reddys LaboratoriesPairCorr
  0.83TAK Takeda PharmaceuticalPairCorr
  0.63ZTS Zoetis IncPairCorr
  0.73LTRN Lantern PharmaPairCorr
  0.69AMGN Amgen IncPairCorr
  0.74ANRO Alto Neuroscience,PairCorr

Moving against Unity Stock

  0.82GILD Gilead SciencesPairCorr
  0.78BMY Bristol Myers Squibb Aggressive PushPairCorr
  0.73ESPR Esperion TherapeuticsPairCorr
  0.66VTRS ViatrisPairCorr
  0.65BHC Bausch Health CompaniesPairCorr
  0.62EWTX Edgewise TherapeuticsPairCorr
  0.56WAT WatersPairCorr
  0.5BFRIW Biofrontera WarrantsPairCorr
  0.4EBS Emergent BiosolutionsPairCorr
  0.34GANX Gain TherapeuticsPairCorr
  0.78BSX Boston Scientific CorpPairCorr
  0.69MNMD Mind MedicinePairCorr
  0.66CPRX Catalyst PharmaceuticalsPairCorr
  0.65ABT Abbott Laboratories Fiscal Year End 22nd of January 2025 PairCorr
  0.51DXCM DexCom IncPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
ELVNCUE
ELYMTFFP
INBXTFFP
MOLNCUE
INBXELYM
MOLNELVN
  
High negative correlations   
ELYMCUE
ELVNELYM
MOLNELYM
MOLNINBX
TFFPCUE
MOLNTFFP

Risk-Adjusted Indicators

There is a big difference between Unity Stock performing well and Unity Biotechnology Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Unity Biotechnology's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Unity Biotechnology Corporate Management

Dr ABCoFounder DirectorProfile
Nathan GuzVice OperationsProfile
Judith CampisiFounderProfile
Daohong MDFounderProfile
Anirvan GhoshCEO DirectorProfile
Jamie MDChief OfficerProfile